 Expert insights by Dr. Adam J. Fein on pharmaceutical economics and the drug distribution system (RSS feed) Current Articles- The AI Advantage: Evolving Patient Engagement Strategies to Improve Outcomes
2025-08-01 11:54 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - Drug Channels News Roundup, July 2025: 340B vs. Patients, Humira Whiplash, Accumulator Fallout, and Pharmacy Struggles
2025-07-29 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - Beyond Throughput: Building Reverification Strategies That Safeguard Access
2025-07-25 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - 2024 Gross-to-Net Realities at 9 Top Drugmakers: A New Era of Market Access
2025-07-22 10:00 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - Informa Connect’s Medicaid Drug Rebate Program Summit
2025-07-21 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - Gross-to-Net Bubble Hits $356B in 2024—But Growth Slows to 10-Year Low
2025-07-15 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - Rewriting the Access Script: A Pharmacist’s View on the Rise of Direct-to-Patient
2025-07-11 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - The Stelara Biosimilar Price War: How PBM-Affiliated Private Labels Are Reshaping the Market
2025-07-08 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - Drug Channels News Roundup, June 2025: PBM Rebate Flow, 340B’s 2024 Boom, IRA Fallout, MFN Legal Risks—and Mark Cuban’s PBM Rant
2025-06-24 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - Transparency vs. Reality: Troubling Lessons from PBM Disclosure Laws (rerun)
2025-06-20 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, and Providers: DCI’s 2025 Update and Competitive Outlook (rerun)
2025-06-19 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - The Top 15 Specialty Pharmacies of 2024: How PBMs, Health Systems, and Independents Are Shaping the Market (rerun)
2025-06-18 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - The Top Pharmacy Benefit Managers of 2024: Market Share and Key Industry Developments (rerun)
2025-06-17 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - The Top 15 U.S. Pharmacies of 2024: Market Shares and Revenues at the Biggest Chains, PBMs, and Specialty Pharmacies (rerun)
2025-06-16 07:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - Starting with the End in Mind: How Pharma Can Build a Smarter Path to Commercialization
2025-06-13 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - The 340B Contract Pharmacy Market in 2025: Big Chains and PBMs Tighten Their Grip
2025-06-10 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - Moving Beyond Mitigation: Cracking the Maximizer Code to Protect Patient Affordability
2025-06-06 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - Pharmacist Salaries and Employment in 2024: Retail Employment Collapse Offset by Hospital Boom
2025-06-03 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - Three Ways GoodRx Is Helping Pharmacies Increase Profitability and Drive Innovation
2025-05-30 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - Drug Channels News Roundup, May 2025: MFN Controversy, Plan Sponsors ♥️ Rebates, PBM Profits, and Fun in Congress
2025-05-28 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - How the IRA’s Part B Coinsurance Inflation Adjustments Can Raise Seniors’ Drug Costs
2025-05-21 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - What’s Next for Retail Pharmacy: Data, Debate, and Disruption (NEW Live Video Webinar)
2025-05-20 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - Resetting the Walk-Away Price: How GoodRx Data Reveals New Realities of Prescription Abandonment
2025-05-16 10:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - How Large PBMs Make Money Today: A 2025 Drug Channels Update
2025-05-13 06:30 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.) - From Barriers to Bridges: Rethinking Medication Access for 2025
2025-05-09 04:00 UTC by noreply@blogger.com (Adam J. Fein, Ph.D.)
Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative. |